Delayed booster dosing improves human antigen-specific Ig and B

medRxiv - The Preprint Server for Health Sciences

JCI Insight - Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine

Frontiers Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History

Nanostrategies to Develop Current Antiviral Vaccines

Immune memory to SARS-CoV-2 Omicron BA.1 breakthrough infections: To change the vaccine or not?

A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses

Frontiers Low switched memory B cells are associated with no humoral response after SARS-CoV-2 vaccine boosters in kidney transplant recipients

Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors

Safety and immunogenicity of seven COVID-19 vaccines as a third dose ( booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV- BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity

SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals - eBioMedicine

Vaccines, Free Full-Text

Vaccines, Free Full-Text

New insights into human immune memory from SARS‐CoV‐2 infection and vaccination - Hartley - 2022 - Allergy - Wiley Online Library